by admin | Sep 11, 2024 | News
We are pleased to announce that ExogenusTherapeutics has been granted another patent in Japan! This is the second patent granted in this region, and the first one to be granted within the family entitled “Compositions comprising small extracellular vesicles...
by admin | Jun 5, 2024 | News
Joana Correia, Founder and CEO of Exogenus Therapeutics, will be a featured speaker at Exosomes Europe, taking place in London on June 5th and 6th. Joana will present a talk titled “Extracellular vesicles in human health: opportunities and challenges,”...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
